Come up with a name for your new list and we'll add to it:
Accuitis raised a round of funding on March 20, 2015. Investors include
Bio/Med Investor Network.
Accuitis is engaged in the acquisition and development of pharmaceuticals targeting niche, orphan, and underserved disease states. The company's lead product is a transformational first in class treat…